IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Goodin
Douglas S
DS
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D003711:Demyelinating Diseases / Q000188:drug therapy*; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000517:prevention & control*; D013997:Time Factors
D000276:Adjuvants, Immunologic; D016899:Interferon-beta; D000068556:Interferon beta-1a